Organizations collaborate to develop international von Willebrand Disease guidelines
The American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World
Read moreHematology
New resource for survivors from NCCN helps guide life after cancer diagnosis and treatment
New NCCN guidelines for patients: Survivorship series provides expert advice to help cancer survivors sustain better health while monitoring for any long-term side effects or recurrences
Read moreAn explanation for the lack of blood oxygenation detected in many COVID-19 patients
One of the physiopathological characteristics of COVID-19 that has most baffled the scientific and medical community is what is known as “silent hypoxemia” or “happy hypoxia”.
Read moreDiscovery of aging mechanism for hematopoietic stem cells
Limited rejuvenation of aged hematopoietic stem cells in young bone marrow niche
Read moreNew toolkit aims to improve quality of thrombosis data in COVID-19 trials
The ASH Research Collaborative and International Society on Thrombosis and Haemostasis define thrombosis-related endpoints to inform COVID-19 clinical trial design
Read moreCancer researchers identify potential new class of drugs to treat blood and bone marrow cancers
Cleveland Clinic research team publishes findings in Blood Cancer Discovery
Read moreExperience “Innovation Uninterrupted” with Sysmex America at AACC 2020
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, will be exhibiting virtually at the 72nd AACC Annual Scientific Meeting & Clinical Lab Expo, December 14 – 17.
Read more
New analysis method for predicting the risks and effects of immunotherapy
In a new study, researchers at Uppsala University have been able to show differences in how Rituximab, a monoclonal antibody drug, interacts with the blood of healthy individuals compared to patients with chronic lymphocytic leukaemia.
Read moreUsing light, red blood cells and a honey bee peptide to deliver therapeutic proteins
Protein therapies are often more potent and selective toward their biochemical targets than other types of drugs, particularly small molecules.
Read moreHow blood and wealth can predict future disability
Peer Reviewed – Survey – Humans
Read moreCHOP Researchers Find Elevated Biomarker Related to Blood Vessel Damage in All Children with SARS-CoV-2 Regardless of Disease Severity
Researchers at Children’s Hospital of Philadelphia (CHOP) have found elevated levels of a biomarker related to blood vessel damage in children with SARS-CoV-2 infection, even if the children had minimal or no symptoms of COVID-19. They also found that a high proportion of children with SARS-CoV-2 infection met clinical and diagnostic criteria for thrombotic microangiopathy (TMA). TMA is a syndrome that involves clotting in the small blood vessels and has been identified as a potential cause for severe manifestations of COVID-19 in adults.
Read moreNew method to boost supply of life-saving stem cells
Haematopoietic stem cell scarcity is one of the biggest barriers to the development of new and improved treatments for blood cancers and disorders
Read more